← back to search

Ling Wang

Hebei Medical University · CN
🔎 Find collaborators in Oncology · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Bone health and treatments, Bone Metabolism and Diseases, and Cancer, Lipids, and Metabolism.
h-index
15
citations
899
works
62
NIH funding
primary concept
email

Recent publications

Development and validation of the nomogram of high fascial compartment pressure with pilon fracture
International Orthopaedics 2025cited by 4position: middledoi
Single-Cell RNA-Seq Uncovers Cellular Heterogeneity from Deep Fascia in Necrotizing Fasciitis Patients
Journal of Inflammation Research 2025cited by 2position: middledoi
Immunogenic cell death: A promising mechanism involving different therapeutic strategies for liver cancer
International Journal of Cancer 2025cited by 2position: middledoi
Novel Proteomic Insights into Hip Fractures in the Elderly: Unraveling Immunologic Biomarkers, Temporal Expression Patterns, and Clinical Correlations
Journal of Inflammation Research 2025cited by 1position: middledoi
Establishment of fracture blister model and analysis of plasma protein markers in rats
Frontiers in Immunology 2025cited by 0position: middledoi
Unraveling the genetic basis of the causal association between inflammatory cytokines and osteonecrosis
Frontiers in Endocrinology 2024cited by 9position: middledoi
Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma
Scientific Reports 2024cited by 4position: lastdoi
Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma
Scientific Reports 2024cited by 2position: lastdoi
Role of co‑inhibitory molecules in the treatment of psoriasis (Review)
Experimental and Therapeutic Medicine 2024cited by 1position: lastdoi
Single-cell RNA sequencing in orthopedic research
Bone Research 2023cited by 57position: middledoi
Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects
Cancer Management and Research 2023cited by 20position: lastdoi
Single-cell RNA-seq reveals cellular heterogeneity from deep fascia in patients with acute compartment syndrome
Frontiers in Immunology 2023cited by 19position: middledoi
Risk factors for short-term mortality in elderly hip fracture patients with complicated heart failure in the ICU: A MIMIC-IV database analysis using nomogram
Journal of Orthopaedic Surgery and Research 2023cited by 11position: middledoi
Decoding the immune landscape following hip fracture in elderly patients: unveiling temporal dynamics through single-cell RNA sequencing
Immunity & Ageing 2023cited by 9position: middledoi
Inflammation-related proteomics demonstrate landscape of fracture blister fluid in patients with acute compartment syndrome
Frontiers in Immunology 2023cited by 9position: middledoi
Cytokine patterns in the blister fluid and plasma of patients with fracture blisters
International Immunopharmacology 2023cited by 9position: middledoi
The intriguing roles of Siglec family members in the tumor microenvironment
Biomarker Research 2022cited by 42position: lastdoi
Siglec-15 as a New Perspective Therapy Target in Human Giant Cell Tumor of Bone
Current Oncology 2022cited by 10position: lastdoi
The promising roles of macrophages in geriatric hip fracture
Frontiers in Cell and Developmental Biology 2022cited by 6position: middledoi
Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway
Frontiers in Oncology 2021cited by 59position: middledoi
FTY720 Inhibits the Development of Collagen-Induced Arthritis in Mice by Suppressing the Recruitment of CD4+ T Lymphocytes
Drug Design Development and Therapy 2021cited by 15position: middledoi
The blister occurring in severe tibial plateau fractures (Schatzker V–VI) decreases the risk of acute compartment syndrome
International Orthopaedics 2021cited by 10position: middledoi
Blood transfusion practices affect CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 cells and the clinical outcome of geriatric patients with hip fracture
Aging 2021cited by 6position: firstdoi
The Updated Status and Future Direction of Immunotherapy Targeting B7-H1/PD-1 in Osteosarcoma
Cancer Management and Research 2021cited by 1position: lastdoi
hsa_circ0021347 as a Potential Target Regulated by B7-H3 in Modulating the Malignant Characteristics of Osteosarcoma
BioMed Research International 2019cited by 24position: firstdoi
B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
Cancer Cell International 2018cited by 55position: firstdoi
B7‑H3 promotes malignant progression of muscle‑invasive bladder cancer
Oncology Reports 2018cited by 14position: middledoi
A multicenter retrospective study of artificial joint replacement on giant cell tumor in distal femur
Zhonghua guke zazhi 2018cited by 1position: middledoi
B7-H4 overexpression is essential for early hepatocellular carcinoma progression and recurrence
Oncotarget 2017cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yingze Zhang · Hebei Medical University8 papers (2019–2024)Zhiyong Hou · Hebei Medical University6 papers (2023–2025)Fubiao Kang · Chinese PLA General Hospital6 papers (2017–2025)Lili Qi · Tongji University5 papers (2021–2024)Guochuan Zhang · Hebei Medical University5 papers (2018–2024)Yubin Long · Hospital of Hebei Province5 papers (2023–2025)Feifei Zhao · Hebei Medical University3 papers (2023–2024)Yining Lu · Hebei Medical University3 papers (2023–2025)Qi Zhang · Jilin University3 papers (2022–2024)Wei Chen · Wuhan Institute of Technology3 papers (2021–2023)Yiran Li · Harbin Normal University2 papers (2023–2023)Tao Wang · Hebei Medical University2 papers (2023–2025)Tao Wang · Xuan Wu Hospital of the Capital Medical University2 papers (2023–2025)Yingze Zhang · Qingdao University2 papers (2022–2023)Yingze Zhang · Qingdao University2 papers (2025–2025)Jialiang Guo · Hebei Medical University2 papers (2021–2023)Jin Lin · Hebei Medical University2 papers (2025–2025)Yan Pei · Hebei Medical University2 papers (2024–2025)Xinbo Liu · Zhejiang Chinese Medical University2 papers (2018–2022)Kui-Ying Jiang · Capital Medical University2 papers (2022–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Molecular Biology →